Option Care Health announced that it anticipates completing the remaining $75M of repurchases in the fourth quarter under the original authorization. In addition, the company’s board of directors approved an increase to its share repurchase program authorization from $250M to $500M. The program has no specified expiration date. The extent to which the company repurchases additional shares, and the timing of such repurchases, will depend upon a variety of factors, including market conditions, regulatory requirements, and other corporate considerations, as determined by the company’s management.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on OPCH:
- Third Point buys T-Mobile, boosts Microsoft in Q3
- Option Care Health price target lowered to $35 from $41 at Barrington
- Option Care Health price target lowered to $35 from $39 at Deutsche Bank
- Option Care Health Announces Financial Results for the Third Quarter Ended September 30, 2023
- Option Care Health sees 2023 revenue $4.23B-$4.28B, consensus $4.28B